Drugs / tPA
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01835067 | Sep 2014 → Nov 2019 | retinal vascular disorder, wet macular degeneration | King's College Hospital NHS Trust | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tPA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01835067 ↗ |
| Route | Intravitreal | “Single intravitreal injection of 50 micrograms tPA in 0.05 mls” NCT01835067 ↗ |